RARE
Ultragenyx Pharmaceutical Inc.
Company overview
- Market capitalization
- $1.42B
- Employees
- 1,371
- Latest publication
- 2026-09-29
About Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme replacement therapy for the treatment of children and adults with Mucopolysaccharidosis VII; Dojolvi for the treatment of long-chain fatty acid oxidation disorders; and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia. The company's products candidates that are in Phase 3 clinical trials include UX143, a human monoclonal antibody for the treatment of osteogenesis imperfecta; UX111, an AAV9 gene therapy product candidate for the treatment of patients with Sanfilippo syndrome type A, or MPS IIIA, a rare lysosomal storage disease; DTX401, an adeno-associated virus 8 (AAV8) gene therapy clinical candidate for the treatment of patients with glycogen storage disease type Ia; DTX301, an AAV8 gene therapy for the treatment of patients with ornithine transcarbamylase; and GTX-102, an antisense oligonucleotide for the treatment of Angelman syndrome. It also develops UX701, an adeno-associated AAV9 gene therapy which is in Phase 2 clinical trial for the treatment of Wilson liver disease. The company has collaboration and license agreement with Kyowa Kirin Co., Ltd.; Saint Louis University; Baylor Research Institute; REGENXBIO Inc.; GeneTx; Mereo; University of Pennsylvania; Regeneron; and Abeona. Ultragenyx Pharmaceutical Inc. was incorporated in 2010 and is headquartered in Novato, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20202020-03-31 · USD | Q2 20192019-06-30 · USD | Q1 20192019-03-31 · USD | Q4 20182018-12-31 · USD | Q3 20182018-09-30 · USD | Q2 20182018-06-30 · USD | Q1 20182018-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 214,000,000USD | 36,309,000USD | 24,149,000USD | 18,172,000USD | 16,261,000USD | 11,763,000USD | 12,794,000USD | 10,677,000USD |
| Research Development | 167,000,000USD | 112,961,000USD | 96,045,000USD | 78,105,000USD | 71,618,000USD | 70,041,000USD | 76,835,000USD | 75,504,000USD |
| Selling General Administrative | 88,000,000USD | 47,516,000USD | 39,812,000USD | 38,829,000USD | 34,476,000USD | 31,095,000USD | 30,718,000USD | 31,435,000USD |
| Total Operating Expenses | 255,000,000USD | 160,477,000USD | 135,857,000USD | 116,934,000USD | 106,094,000USD | 101,136,000USD | 107,553,000USD | 106,939,000USD |
| Operating Income | -75,000,000USD | -120,665,000USD | -112,474,000USD | -99,214,000USD | -90,340,000USD | -89,646,000USD | -94,900,000USD | -96,487,000USD |
| Total Other Income Expense Net | -16,000,000USD | 2,049,000USD | 13,515,000USD | 2,674,000USD | 2,640,000USD | 2,583,000USD | 42,274,000USD | 126,779,000USD |
| Interest Income | 5,000,000USD | 2,919,000USD | 4,063,000USD | 3,086,000USD | — | — | — | — |
| Income Before Tax | -91,000,000USD | -118,616,000USD | -98,959,000USD | -96,540,000USD | -87,700,000USD | -87,063,000USD | -52,626,000USD | 30,292,000USD |
| Income Tax Expense | 1,000,000USD | 409,000USD | 213,000USD | 216,000USD | 126,000USD | 247,000USD | 102,000USD | 39,000USD |
| Net Income | -92,000,000USD | -119,025,000USD | -99,172,000USD | -96,756,000USD | -87,826,000USD | -87,310,000USD | -52,728,000USD | 30,253,000USD |
| Cost Of Revenue | — | -3,503,000USD | 766,000USD | 452,000USD | 507,000USD | 273,000USD | 141,000USD | 225,000USD |
| Gross Profit | — | 39,812,000USD | 23,383,000USD | 17,720,000USD | 15,754,000USD | 11,490,000USD | 12,653,000USD | 10,452,000USD |
| Interest Expense | — | 8,082,000USD | 1,135,000USD | 1,135,000USD | 0USD | 0USD | 0USD | 0USD |
| Net Interest Income | — | -5,163,000USD | 4,063,000USD | 3,086,000USD | — | — | — | — |
| Tax Provision | — | 409,000USD | 213,000USD | 216,000USD | — | — | — | — |
| Net Income From Continuing Ops | — | -119,025,000USD | -99,172,000USD | -96,756,000USD | -87,826,000USD | -87,310,000USD | -52,728,000USD | 30,253,000USD |
| Ebit | — | -110,534,000USD | -98,959,000USD | -96,540,000USD | -90,340,000USD | -89,646,000USD | -94,900,000USD | -96,487,000USD |
| Ebitda | — | -107,682,000USD | -96,853,000USD | -94,421,000USD | -87,397,000USD | -85,291,000USD | -88,820,000USD | -90,327,000USD |
| Depreciation And Amortization | — | 2,852,000USD | 2,106,000USD | 2,119,000USD | 2,943,000USD | 4,355,000USD | 6,080,000USD | 6,160,000USD |
| Reconciled Depreciation | — | 2,852,000USD | 2,106,000USD | 2,119,000USD | 2,943,000USD | 4,355,000USD | 6,080,000USD | 6,160,000USD |
| Non Operating Income Net Other | — | 2,463,000USD | 3,687,000USD | 2,674,000USD | — | 2,583,000USD | 42,274,000USD | 126,779,000USD |
| Net Income Applicable To Common Shares | — | -119,025,000USD | -99,172,000USD | -96,756,000USD | -87,826,000USD | -87,310,000USD | -52,728,000USD | 30,253,000USD |
| Minority Interest | — | — | — | — | 0USD | 0USD | 0USD | 0USD |
| Discontinued Operations | — | — | — | — | 0USD | 0USD | 0USD | 0USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD | FY 20142014-12-31 · USD | FY 20122012-12-31 · USD | FY 20112011-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 51,495,000USD | 2,612,000USD | 133,000USD | 0USD | — | — |
| Cost Of Revenue | 1,146,000USD | 1,000USD | 183,204,000USD | 0USD | — | — |
| Gross Profit | 50,349,000USD | 2,611,000USD | 133,000USD | 0USD | — | — |
| Research Development | 293,998,000USD | 231,644,000USD | 183,204,000USD | 45,967,000USD | 12,641,000USD | 4,717,000USD |
| Selling General Administrative | 127,724,000USD | 99,909,000USD | 64,936,000USD | 10,811,000USD | 3,344,000USD | 1,844,000USD |
| Total Operating Expenses | 421,722,000USD | 331,553,000USD | 248,140,000USD | 56,778,000USD | 15,985,000USD | 6,561,000USD |
| Operating Income | -371,373,000USD | -328,942,000USD | -248,007,000USD | -56,778,000USD | -15,985,000USD | -6,561,000USD |
| Interest Income | 9,542,000USD | 4,074,000USD | 3,789,000USD | — | — | — |
| Interest Expense | 0USD | 0USD | 0USD | 0USD | 0USD | 270,000USD |
| Net Interest Income | 9,542,000USD | 4,074,000USD | 3,789,000USD | — | — | — |
| Income Before Tax | -197,097,000USD | -318,338,000USD | -245,839,000USD | -59,802,000USD | -16,334,000USD | -6,849,000USD |
| Income Tax Expense | 514,000USD | -16,199,000USD | 35,000USD | -684,000USD | -350,000USD | 248,000USD |
| Tax Provision | 514,000USD | -16,199,000USD | 35,000USD | — | — | — |
| Net Income | -197,611,000USD | -302,139,000USD | -245,874,000USD | -59,802,000USD | -16,334,000USD | -6,849,000USD |
| Net Income From Continuing Ops | -197,611,000USD | -302,139,000USD | -245,874,000USD | -59,802,000USD | — | — |
| Ebit | -197,097,000USD | -328,942,000USD | -248,007,000USD | -56,778,000USD | -16,334,000USD | -6,579,000USD |
| Ebitda | -177,559,000USD | -323,117,000USD | -244,583,000USD | -56,094,000USD | -16,021,000USD | -6,545,000USD |
| Depreciation And Amortization | 19,538,000USD | 5,825,000USD | 3,424,000USD | 684,000USD | 313,000USD | 34,000USD |
| Reconciled Depreciation | 19,538,000USD | 5,825,000USD | — | — | — | — |
| Total Other Income Expense Net | 174,276,000USD | 10,604,000USD | 2,168,000USD | -3,024,000USD | -349,000USD | -288,000USD |
| Non Operating Income Net Other | 174,276,000USD | 10,604,000USD | 2,168,000USD | -3,024,000USD | — | — |
| Net Income Applicable To Common Shares | -197,611,000USD | -302,139,000USD | -245,874,000USD | -64,610,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,264,000,000USD | 1,296,000,000USD | 1,532,000,000USD | 1,190,445,000USD | 1,306,265,000USD | 1,311,927,000USD | 1,503,456,000USD | 1,538,363,000USD |
| Cash And Equivalents | 125,000,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 606,000,000USD | 657,000,000USD | 951,000,000USD | 643,206,000USD | 719,788,000USD | 699,155,000USD | 817,123,000USD | 799,608,000USD |
| Other Current Assets | 55,000,000USD | 68,000,000USD | 47,000,000USD | 41,289,000USD | 71,441,000USD | 59,845,000USD | 40,290,000USD | 41,365,000USD |
| Other Non Current Assets | 63,000,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 1,548,000,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 351,000,000USD | 325,000,000USD | 384,000,000USD | 340,022,000USD | 293,244,000USD | 291,668,000USD | 344,153,000USD | 285,008,000USD |
| Other Current Liabilities | 15,000,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 41,000,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | -291,000,000USD | -236,000,000USD | -80,000,000USD | 9,158,999USD | 151,286,000USD | 144,246,000USD | 255,297,000USD | 346,827,000USD |
| Total Equity Including Noncontrolling Interest | -284,000,000USD | — | — | — | — | — | — | — |
| Net Receivables | 200,000,000USD | 121,000,000USD | 159,000,000USD | 114,643,000USD | 124,464,000USD | 98,839,000USD | 121,801,000USD | 93,301,000USD |
| Inventory | 59,000,000USD | 55,000,000USD | 52,000,000USD | 52,200,000USD | 46,498,000USD | 46,031,000USD | 45,007,000USD | 43,334,000USD |
| Property Plant Equipment Net | 235,000,000USD | 239,000,000USD | 267,000,000USD | 249,961,000USD | 255,763,000USD | 260,906,000USD | 265,929,000USD | 272,448,000USD |
| Goodwill | 44,000,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 172,000,000USD | 174,000,000USD | 176,000,000USD | 172,943,000USD | 174,733,000USD | 176,524,000USD | 178,314,000USD | 164,942,000USD |
| Accounts Payable | 39,000,000USD | 42,000,000USD | 31,000,000USD | 40,573,000USD | 34,242,000USD | 47,450,000USD | 38,756,000USD | 35,990,000USD |
| Common Stock | 0USD | — | — | 96,000USD | 96,000USD | 94,000USD | 92,000USD | 92,000USD |
| Retained Earnings | -4,809,000,000USD | -4,717,000,000USD | -4,532,000,000USD | -4,403,288,000USD | -4,222,875,000USD | -4,107,924,000USD | -3,956,844,000USD | -3,823,459,000USD |
| Accumulated Other Comprehensive Income | 0USD | 10,000,000USD | 1,000,000USD | 8,810,999USD | -268,000USD | -341,000USD | -643,000USD | 896,000USD |
| Total Liab | — | 1,525,000,000USD | 1,605,000,000USD | 1,174,286,000USD | 1,147,979,000USD | 1,160,681,000USD | 1,241,159,000USD | 1,184,536,000USD |
| Other Current Liab | — | 211,000,000USD | 272,000,000USD | 221,762,000USD | 247,236,000USD | 233,731,000USD | 295,100,000USD | 238,594,000USD |
| Capital Stock | — | 0USD | 0USD | 96,000USD | 96,000USD | 94,000USD | 92,000USD | 92,000USD |
| Good Will | — | 44,000,000USD | 44,000,000USD | 44,406,000USD | 44,406,000USD | 44,406,000USD | 44,406,000USD | 44,406,000USD |
| Cash | — | 175,000,000USD | 434,000,000USD | 212,336,000USD | 166,106,000USD | 127,055,000USD | 173,729,000USD | 150,619,000USD |
| Cash And Short Term Investments | — | 413,000,000USD | 693,000,000USD | 435,074,000USD | 477,385,000USD | 494,440,000USD | 610,025,000USD | 621,608,000USD |
| Net Debt | — | 1,025,000,000USD | 842,000,000USD | 672,468,000USD | -129,809,000USD | -88,782,000USD | -133,390,000USD | -116,538,000USD |
| Short Term Debt | — | 72,000,000USD | 81,000,000USD | 77,687,000USD | 11,766,000USD | 10,487,000USD | 10,297,000USD | 10,424,000USD |
| Short Long Term Debt Total | — | 1,200,000,000USD | 1,276,000,000USD | 884,804,000USD | 36,297,000USD | 38,273,000USD | 40,339,000USD | 34,081,000USD |
| Long Term Investments | — | 121,000,000USD | 57,000,000USD | 22,067,000USD | 51,454,000USD | 68,563,000USD | 135,004,000USD | 203,086,000USD |
| Short Term Investments | — | 238,000,000USD | 259,000,000USD | 222,738,000USD | 311,279,000USD | 367,385,000USD | 436,296,000USD | 470,989,000USD |
| Common Stock Shares Outstanding | — | 100,600,000shares | 99,900,000shares | 99,771,297shares | 98,460,445shares | 96,288,650shares | 95,681,451shares | 95,493,996shares |
| Non Current Assets Total | — | 639,000,000USD | 581,000,000USD | 547,239,000USD | 586,477,000USD | 612,772,000USD | 686,333,000USD | 738,755,000USD |
| Non Current Liabilities Total | — | 1,200,000,000USD | 1,221,000,000USD | 834,264,000USD | 854,735,000USD | 869,013,000USD | 897,006,000USD | 899,528,000USD |
| Non Current Liabilities Other | — | 42,000,000USD | 20,000,000USD | 18,780,000USD | 17,398,000USD | 17,123,000USD | 17,082,000USD | 16,127,000USD |
| Non Currrent Assets Other | — | 55,000,000USD | 35,000,000USD | 57,862,000USD | 60,121,000USD | 62,373,000USD | 62,680,000USD | 53,873,000USD |
| Net Working Capital | — | 332,000,000USD | 567,000,000USD | 303,184,000USD | 426,544,000USD | 407,487,000USD | 472,970,000USD | 514,600,000USD |
| Unclassified Non Current Liabilities | — | 1,158,000,000USD | 1,201,000,000USD | 815,484,000USD | 837,337,000USD | 851,890,000USD | 879,924,000USD | 883,401,000USD |
| Unclassified Equity | — | 4,471,000,000USD | 4,451,000,000USD | 4,403,444,000USD | 4,374,237,000USD | 4,252,323,000USD | 4,212,600,000USD | 4,169,206,000USD |
| Property Plant Equipment Gross | — | — | 380,000,000USD | — | — | — | 378,411,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,532,000,000USD | 1,503,456,000USD | 1,491,013,000USD | 1,545,444,000USD | 1,522,397,000USD | 1,759,555,000USD | 1,135,496,000USD | 719,558,000USD |
| Intangible Assets | 176,000,000USD | 178,314,000USD | 166,271,000USD | 160,105,000USD | 130,788,000USD | 131,113,000USD | 129,000,000USD | 129,223,000USD |
| Other Current Assets | 47,000,000USD | 40,290,000USD | 47,616,000USD | 68,926,000USD | 55,745,000USD | 57,630,000USD | 51,397,000USD | 42,858,000USD |
| Total Liab | 1,605,000,000USD | 1,241,159,000USD | 1,215,599,000USD | 1,192,950,000USD | 599,836,000USD | 605,180,000USD | 481,732,000USD | 110,650,000USD |
| Total Stockholder Equity | -80,000,000USD | 255,297,000USD | 275,414,000USD | 352,494,000USD | 922,561,000USD | 1,154,375,000USD | 653,764,000USD | 608,908,000USD |
| Other Current Liab | 272,000,000USD | 295,100,000USD | 225,728,000USD | 204,678,000USD | 145,555,000USD | 108,491,000USD | 83,194,000USD | 62,450,000USD |
| Capital Stock | 0USD | 92,000USD | 82,000USD | 70,000USD | 69,000USD | 67,000USD | 58,000USD | 51,000USD |
| Retained Earnings | -4,532,000,000USD | -3,956,844,000USD | -3,387,661,000USD | -2,781,022,000USD | -2,073,601,000USD | -1,619,576,000USD | -1,433,010,000USD | -1,030,283,000USD |
| Good Will | 44,000,000USD | 44,406,000USD | 44,406,000USD | 44,406,000USD | 44,406,000USD | 44,406,000USD | 44,406,000USD | 44,406,000USD |
| Cash | 434,000,000USD | 173,729,000USD | 213,584,000USD | 132,944,000USD | 307,584,000USD | 713,526,000USD | 433,584,000USD | 113,432,000USD |
| Cash And Short Term Investments | 693,000,000USD | 610,025,000USD | 577,209,000USD | 747,762,000USD | 740,196,000USD | 1,201,533,000USD | 755,230,000USD | 459,706,000USD |
| Total Current Assets | 951,000,000USD | 817,123,000USD | 732,184,000USD | 883,899,000USD | 856,604,000USD | 1,295,304,000USD | 851,017,000USD | 522,369,000USD |
| Total Current Liabilities | 384,000,000USD | 344,153,000USD | 280,437,000USD | 261,210,000USD | 181,368,000USD | 189,609,000USD | 103,300,000USD | 74,725,000USD |
| Net Debt | 842,000,000USD | -133,390,000USD | -170,415,000USD | -101,351,000USD | -265,614,000USD | -665,299,000USD | -396,592,000USD | -113,432,000USD |
| Short Term Debt | 81,000,000USD | 10,297,000USD | 12,595,000USD | 11,779,000USD | 11,066,000USD | 8,976,000USD | 7,235,000USD | — |
| Short Long Term Debt Total | 1,276,000,000USD | 40,339,000USD | 43,169,000USD | 31,593,000USD | 41,970,000USD | 48,227,000USD | 36,992,000USD | — |
| Long Term Investments | 57,000,000USD | 135,004,000USD | 199,901,000USD | 154,501,000USD | 258,933,000USD | 10,506,000USD | 32,926,000USD | 0USD |
| Short Term Investments | 259,000,000USD | 436,296,000USD | 363,625,000USD | 614,818,000USD | 432,612,000USD | 488,007,000USD | 321,646,000USD | 346,274,000USD |
| Net Receivables | 159,000,000USD | 121,801,000USD | 73,390,000USD | 40,445,000USD | 44,432,000USD | 23,093,000USD | 32,844,000USD | 12,740,000USD |
| Inventory | 52,000,000USD | 45,007,000USD | 33,969,000USD | 26,766,000USD | 16,231,000USD | 13,048,000USD | 11,546,000USD | 7,065,000USD |
| Accounts Payable | 31,000,000USD | 38,756,000USD | 42,114,000USD | 43,274,000USD | 17,138,000USD | 12,923,000USD | 12,871,000USD | 12,275,000USD |
| Property Plant Equipment Net | 267,000,000USD | 265,929,000USD | 290,566,000USD | 259,726,000USD | 176,183,000USD | 114,039,000USD | 74,676,000USD | 20,046,000USD |
| Property Plant Equipment Gross | 380,000,000USD | 378,411,000USD | 373,967,000USD | 349,068,000USD | 226,221,000USD | 114,039,000USD | 74,676,000USD | 20,046,000USD |
| Accumulated Other Comprehensive Income | 1,000,000USD | -643,000USD | 647,000USD | -6,573,000USD | -1,404,000USD | 689,000USD | -147,000USD | -633,000USD |
| Common Stock Shares Outstanding | 98,600,000shares | 90,538,118shares | 73,543,862shares | 69,914,225shares | 67,795,540shares | 60,845,550shares | 56,576,885shares | 49,775,223shares |
| Non Current Assets Total | 581,000,000USD | 686,333,000USD | 758,829,000USD | 661,545,000USD | 665,793,000USD | 464,251,000USD | 284,479,000USD | 197,189,000USD |
| Non Current Liabilities Total | 1,221,000,000USD | 897,006,000USD | 935,162,000USD | 931,740,000USD | 418,468,000USD | 415,571,000USD | 378,432,000USD | 35,925,000USD |
| Non Current Liabilities Other | 20,000,000USD | 17,082,000USD | 12,205,000USD | 4,820,000USD | 385,162,000USD | 382,265,000USD | 345,126,000USD | 4,759,000USD |
| Non Currrent Assets Other | 35,000,000USD | 62,680,000USD | 57,685,000USD | 48,338,000USD | 20,558,000USD | 8,812,000USD | 3,471,000USD | 3,514,000USD |
| Net Working Capital | 567,000,000USD | 472,970,000USD | 451,747,000USD | 622,689,000USD | 675,236,000USD | 1,105,695,000USD | 747,717,000USD | 447,644,000USD |
| Unclassified Non Current Liabilities | 1,201,000,000USD | 879,924,000USD | 922,957,000USD | -16,673,000USD | -387,564,000USD | -376,320,000USD | -348,675,000USD | -35,925,000USD |
| Unclassified Equity | 4,451,000,000USD | 4,212,600,000USD | 3,662,264,000USD | 3,139,949,000USD | 2,997,428,000USD | 2,773,128,000USD | 2,086,805,000USD | 1,639,722,000USD |
| Common Stock | — | 92,000USD | 82,000USD | 70,000USD | 69,000USD | 67,000USD | 58,000USD | 51,000USD |
| Current Deferred Revenue | — | — | 196,486,000USD | 1,479,000USD | 7,609,000USD | 59,219,000USD | — | — |
| Unclassified Current Liabilities | — | — | -196,486,000USD | — | — | — | — | — |
| Deferred Long Term Liab | — | — | — | 31,667,000USD | 33,306,000USD | 33,306,000USD | 33,306,000USD | 31,166,000USD |
| Other Liab | — | — | — | 911,926,000USD | 387,564,000USD | 376,320,000USD | 348,675,000USD | 35,925,000USD |
| Other Assets | — | — | — | 16,846,000USD | 20,558,000USD | 8,812,000USD | 3,471,000USD | 3,514,000USD |
| Net Tangible Assets | — | — | — | 147,983,000USD | 758,399,000USD | 978,856,000USD | 480,358,000USD | 435,279,000USD |
| Unclassified Non Current Assets | — | — | — | -22,377,000USD | 14,367,000USD | 146,563,000USD | -3,471,000USD | -3,514,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -185,000,000USD | -128,556,000USD | -180,413,000USD | -114,951,000USD | -151,080,000USD | -133,385,000USD | -133,516,000USD | -131,598,000USD |
| Depreciation | 8,000,000USD | 8,785,000USD | 8,606,000USD | -11,770,000USD | 8,990,000USD | 9,079,000USD | 8,757,000USD | 8,862,000USD |
| Stock Based Compensation | 30,000,000USD | 37,289,000USD | 37,010,000USD | 38,529,000USD | 39,917,000USD | 40,164,000USD | 41,569,000USD | 39,371,000USD |
| Other Non Cash Items | 1,000,000USD | -17,935,000USD | -11,485,000USD | 1,733,000USD | -7,669,000USD | -18,112,000USD | -14,633,000USD | -9,956,000USD |
| Change To Account Receivables | 19,000,000USD | -33,834,000USD | 5,425,000USD | -12,653,000USD | 10,062,000USD | -20,640,000USD | 9,792,000USD | 2,158,000USD |
| Change To Inventory | -4,000,000USD | 150,000USD | -5,595,000USD | 208,000USD | -763,000USD | -2,456,000USD | -2,500,000USD | -4,127,000USD |
| Change In Working Capital | -51,000,000USD | 588,000USD | 54,859,000USD | -21,814,000USD | -56,633,000USD | 22,751,000USD | 30,828,000USD | 16,358,000USD |
| Total Cash From Operating Activities | -197,000,000USD | -99,829,000USD | -91,423,000USD | -108,273,000USD | -166,475,000USD | -79,503,000USD | -66,995,000USD | -76,963,000USD |
| Capital Expenditures | -1,000,000USD | -938,000USD | -1,278,000USD | 12,540,000USD | -16,324,000USD | -654,000USD | -1,617,000USD | -4,509,000USD |
| Free Cash Flow | -198,000,000USD | -100,767,000USD | -92,701,000USD | -95,733,000USD | -182,799,000USD | -80,157,000USD | -68,612,000USD | -81,472,000USD |
| Investments | -43,000,000USD | -71,582,000USD | 117,182,000USD | 71,175,000USD | 119,890,000USD | 102,735,000USD | -275,502,000USD | 60,564,000USD |
| Total Cashflows From Investing Activities | -49,000,000USD | -72,247,000USD | 117,182,000USD | 71,175,000USD | 119,890,000USD | 102,735,000USD | -275,502,000USD | 60,564,000USD |
| Change In Cash | -251,000,000USD | 221,664,000USD | 26,055,000USD | 49,465,000USD | -44,980,000USD | 23,945,000USD | -330,048,000USD | 367,892,000USD |
| Begin Period Cash Flow | 434,000,000USD | 214,699,000USD | 188,644,000USD | 139,179,000USD | 184,159,000USD | 160,214,000USD | 490,262,000USD | 122,370,000USD |
| End Period Cash Flow | 183,000,000USD | 436,000,000USD | 214,699,000USD | 188,644,000USD | 139,179,000USD | 184,159,000USD | 160,214,000USD | 490,262,000USD |
| Other Cashflows From Investing Activities | -5,000,000USD | 273,000USD | -185,000USD | -308,000USD | -15,780,000USD | -127,000USD | -203,000USD | -2,541,000USD |
| Total Cash From Financing Activities | — | 394,192,000USD | 2,000USD | 83,649,000USD | 157,000USD | 3,186,000USD | 11,174,000USD | 384,939,000USD |
| Issuance Of Capital Stock | — | 6,272,000USD | 0USD | — | — | 0USD | 117,000USD | — |
| Unclassified Financing Cash Flow | — | 387,920,000USD | — | 79,728,000USD | — | — | — | — |
| Other Cashflows From Financing Activities | — | — | 2,000USD | 3,921,000USD | 157,000USD | 3,186,000USD | 11,057,000USD | 384,939,000USD |
| Unclassified Investing Cash Flow | — | — | 1,463,000USD | -12,232,000USD | 32,104,000USD | — | — | 7,050,000USD |
| Sale Purchase Of Stock | — | — | — | — | — | — | — | 58,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -575,000,000USD | -569,183,000USD | -606,639,000USD | -707,421,000USD | -454,025,000USD | -186,566,000USD | -402,727,000USD | -197,611,000USD |
| Depreciation | 35,000,000USD | 35,543,000USD | 26,006,000USD | 18,220,000USD | 13,239,000USD | 12,261,000USD | 8,539,000USD | 19,538,000USD |
| Stock Based Compensation | 153,000,000USD | 158,030,000USD | 135,213,000USD | 130,377,000USD | 104,952,000USD | 85,735,000USD | 81,995,000USD | 80,107,000USD |
| Other Non Cash Items | -56,000,000USD | -52,496,000USD | -12,666,000USD | 118,124,000USD | 11,706,000USD | 21,463,000USD | 1,692,000USD | -156,000USD |
| Change To Account Receivables | -31,000,000USD | -33,598,000USD | -22,778,000USD | -12,068,000USD | -5,432,000USD | 9,840,000USD | -20,104,000USD | -7,583,000USD |
| Change To Inventory | -6,000,000USD | -11,207,000USD | -6,930,000USD | -9,701,000USD | -3,117,000USD | -1,346,000USD | -4,451,000USD | -5,283,000USD |
| Change In Working Capital | -23,000,000USD | 13,918,000USD | -15,101,000USD | 60,235,000USD | -63,236,000USD | 104,663,000USD | -15,943,000USD | -24,790,000USD |
| Total Cash From Operating Activities | -466,000,000USD | -414,188,000USD | -474,806,000USD | -380,465,000USD | -338,695,000USD | -132,220,000USD | -345,383,000USD | -290,566,000USD |
| Capital Expenditures | -6,000,000USD | -7,491,000USD | -46,767,000USD | -146,123,000USD | -73,093,000USD | -43,905,000USD | -24,832,000USD | -4,076,000USD |
| Free Cash Flow | -472,000,000USD | -421,679,000USD | -521,573,000USD | -526,588,000USD | -411,788,000USD | -176,125,000USD | -370,215,000USD | -294,642,000USD |
| Investments | 258,000,000USD | -17,768,000USD | 103,418,000USD | -291,652,000USD | -201,180,000USD | -209,503,000USD | 11,793,000USD | -199,577,000USD |
| Total Cashflows From Investing Activities | 236,000,000USD | -17,768,000USD | 168,000,000USD | -291,652,000USD | -195,372,000USD | -179,121,000USD | -13,039,000USD | -33,331,000USD |
| Total Cash From Financing Activities | 478,000,000USD | 399,241,000USD | 388,142,000USD | 501,208,000USD | 118,552,000USD | 600,272,000USD | 679,306,000USD | 336,853,000USD |
| Issuance Of Capital Stock | 86,000,000USD | 380,983,000USD | 53,299,000USD | 28,507,000USD | 78,943,000USD | 511,215,000USD | 355,243,000USD | 309,025,000USD |
| Change In Cash | 253,465,000USD | -35,240,000USD | 81,798,000USD | -171,984,000USD | -416,709,000USD | 290,050,000USD | 320,719,000USD | 12,484,000USD |
| Begin Period Cash Flow | 184,159,000USD | 219,399,000USD | 137,601,000USD | 309,585,000USD | 726,294,000USD | 436,244,000USD | 115,525,000USD | 103,041,000USD |
| End Period Cash Flow | 436,000,000USD | 184,159,000USD | 219,399,000USD | 137,601,000USD | 309,585,000USD | 726,294,000USD | 436,244,000USD | 115,525,000USD |
| Other Cashflows From Investing Activities | -16,000,000USD | -14,936,000USD | -7,548,000USD | -30,844,000USD | -942,000USD | -5,555,000USD | 11,793,000USD | 170,322,000USD |
| Other Cashflows From Financing Activities | 478,000,000USD | 18,258,000USD | 8,387,000USD | 501,208,000USD | 39,609,000USD | 89,057,000USD | 324,063,000USD | 27,828,000USD |
| Unclassified Financing Cash Flow | -86,000,000USD | — | 326,456,000USD | -10,813,000USD | 38,842,000USD | -13,634,000USD | 14,999,000USD | 10,228,000USD |
| Unclassified Investing Cash Flow | — | 22,427,000USD | 118,897,000USD | 176,967,000USD | 79,843,000USD | 79,842,000USD | -11,793,000USD | — |
| Change To Liabilities | — | — | — | 78,206,000USD | -25,179,000USD | 93,421,000USD | 15,452,000USD | 2,361,000USD |
| Sale Purchase Of Stock | — | — | — | 10,813,000USD | 40,101,000USD | 524,849,000USD | 340,244,000USD | 298,797,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -170,909,000USD | -415,515,000USD | 288,931,000USD | 320,884,000USD | 12,956,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | 48,669,000USD | -169,776,000USD | -18,939,000USD | -167,654,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Geography | Asia Pacific | 7,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | EMEA | 35,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | Latin America | 51,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | North America | 121,000,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Geography | Asia Pacific | 4,000,000 | USD | 0001193125-26-206960 |
| Q1 2026Quarterly · 2026-03-31 | Geography | EMEA | 31,000,000 | USD | 0001193125-26-206960 |
| Q1 2026Quarterly · 2026-03-31 | Geography | Latin America | 42,000,000 | USD | 0001193125-26-206960 |
| Q1 2026Quarterly · 2026-03-31 | Geography | North America | 59,000,000 | USD | 0001193125-26-206960 |
| Q4 2025Quarterly · 2025-12-31 | Geography | Asia Pacific | 5,646,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | EMEA | 30,719,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | Latin America | 38,669,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | North America | 132,537,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | Asia Pacific | 18,000,000 | USD | 0001193125-26-057329 |
| FY 2025Yearly · 2025-12-31 | Geography | EMEA | 108,000,000 | USD | 0001193125-26-057329 |
| FY 2025Yearly · 2025-12-31 | Geography | Latin America | 170,000,000 | USD | 0001193125-26-057329 |
| FY 2025Yearly · 2025-12-31 | Geography | North America | 377,000,000 | USD | 0001193125-26-057329 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Asia Pacific | 5,154,000 | USD | 0001193125-25-265126 |
| Q3 2025Quarterly · 2025-09-30 | Geography | EMEA | 27,878,000 | USD | 0001193125-25-265126 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Latin America | 43,364,000 | USD | 0001193125-25-265126 |
| Q3 2025Quarterly · 2025-09-30 | Geography | North America | 83,537,000 | USD | 0001193125-25-265126 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Asia Pacific | 4,200,000 | USD | 0000950170-25-103290 |
| Q2 2025Quarterly · 2025-06-30 | Geography | EMEA | 26,403,000 | USD | 0000950170-25-103290 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Latin America | 32,967,000 | USD | 0000950170-25-103290 |
| Q2 2025Quarterly · 2025-06-30 | Geography | North America | 102,926,000 | USD | 0000950170-25-103290 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Asia Pacific | 3,000,000 | USD | 0001193125-26-206960 |
| Q1 2025Quarterly · 2025-03-31 | Geography | EMEA | 23,000,000 | USD | 0001193125-26-206960 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Latin America | 55,000,000 | USD | 0001193125-26-206960 |
| Q1 2025Quarterly · 2025-03-31 | Geography | North America | 58,000,000 | USD | 0001193125-26-206960 |
| Q4 2024Quarterly · 2024-12-31 | Geography | Asia Pacific | 3,639,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | EMEA | 25,648,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | Latin America | 18,845,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | North America | 116,515,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | Asia Pacific | 9,000,000 | USD | 0001193125-26-057329 |
| FY 2024Yearly · 2024-12-31 | Geography | EMEA | 80,000,000 | USD | 0001193125-26-057329 |
| FY 2024Yearly · 2024-12-31 | Geography | Latin America | 131,000,000 | USD | 0001193125-26-057329 |
| FY 2024Yearly · 2024-12-31 | Geography | North America | 340,000,000 | USD | 0001193125-26-057329 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Asia Pacific | 2,310,000 | USD | 0001193125-25-265126 |
| Q3 2024Quarterly · 2024-09-30 | Geography | EMEA | 22,222,000 | USD | 0001193125-25-265126 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Latin America | 38,048,000 | USD | 0001193125-25-265126 |
| Q3 2024Quarterly · 2024-09-30 | Geography | North America | 76,914,000 | USD | 0001193125-25-265126 |
| FY 2023Yearly · 2023-12-31 | Geography | Asia Pacific | 2,000,000 | USD | 0001193125-26-057329 |
| FY 2023Yearly · 2023-12-31 | Geography | EMEA | 48,000,000 | USD | 0001193125-26-057329 |
| FY 2023Yearly · 2023-12-31 | Geography | Latin America | 77,000,000 | USD | 0001193125-26-057329 |
| FY 2023Yearly · 2023-12-31 | Geography | North America | 307,000,000 | USD | 0001193125-26-057329 |
| FY 2022Yearly · 2022-12-31 | Geography | Asia Pacific | 1,161,000 | USD | 0000950170-25-023312 |
| FY 2022Yearly · 2022-12-31 | Geography | EMEA | 36,369,000 | USD | 0000950170-25-023312 |
| FY 2022Yearly · 2022-12-31 | Geography | Latin America | 44,711,000 | USD | 0000950170-25-023312 |
| FY 2022Yearly · 2022-12-31 | Geography | North America | 281,088,000 | USD | 0000950170-25-023312 |
| Q1 2022Quarterly · 2022-03-31 | Product | Collaboration And License | 48,413,000 | USD | 0000950170-22-007940 |
| Q1 2022Quarterly · 2022-03-31 | Product | Product | 26,684,000 | USD | 0000950170-22-007940 |
| Q1 2022Quarterly · 2022-03-31 | Product | Royalty | 4,838,000 | USD | 0000950170-22-007940 |
| FY 2021Yearly · 2021-12-31 | Geography | Europe | 26,660,000 | USD | 0000950170-24-017879 |
| FY 2021Yearly · 2021-12-31 | Geography | Japan | 0 | USD | 0000950170-24-017879 |
| FY 2021Yearly · 2021-12-31 | Geography | Latin America | 23,636,000 | USD | 0000950170-24-017879 |
| FY 2021Yearly · 2021-12-31 | Geography | North America | 301,110,000 | USD | 0000950170-24-017879 |
| Q1 2021Quarterly · 2021-03-31 | Product | Collaboration And License | 79,010,000 | USD | 0000950170-22-007940 |
| Q1 2021Quarterly · 2021-03-31 | Product | Product | 16,513,000 | USD | 0000950170-22-007940 |
| Q1 2021Quarterly · 2021-03-31 | Product | Royalty | 3,872,000 | USD | 0000950170-22-007940 |
| FY 2020Yearly · 2020-12-31 | Geography | Europe | 21,318,000 | USD | 0000950170-23-003096 |
| FY 2020Yearly · 2020-12-31 | Geography | Japan | 0 | USD | 0000950170-23-003096 |
| FY 2020Yearly · 2020-12-31 | Geography | Latin America | 12,046,000 | USD | 0000950170-23-003096 |
| FY 2020Yearly · 2020-12-31 | Geography | North America | 237,666,000 | USD | 0000950170-23-003096 |
| Q1 2020Quarterly · 2020-03-31 | Product | Collaboration And License | 27,215,000 | USD | 0001564590-21-023501 |
| Q1 2020Quarterly · 2020-03-31 | Product | Product | 6,479,000 | USD | 0001564590-21-023501 |
| Q1 2020Quarterly · 2020-03-31 | Product | Royalty | 2,615,000 | USD | 0001564590-21-023501 |
| FY 2019Yearly · 2019-12-31 | Geography | All Other | 5,187,000 | USD | 0000950170-22-001284 |
| FY 2019Yearly · 2019-12-31 | Geography | Europe | 12,085,000 | USD | 0000950170-22-001284 |
| FY 2019Yearly · 2019-12-31 | Geography | North America | 86,442,000 | USD | 0000950170-22-001284 |
| Q3 2019Quarterly · 2019-09-30 | Product | Collaboration And License | 21,585,000 | USD | 0001564590-19-040541 |
| Q3 2019Quarterly · 2019-09-30 | Product | Product | 4,215,000 | USD | 0001564590-19-040541 |
| Q2 2019Quarterly · 2019-06-30 | Product | Collaboration And License | 19,247,000 | USD | 0001564590-19-028087 |
| Q2 2019Quarterly · 2019-06-30 | Product | Product | 4,902,000 | USD | 0001564590-19-028087 |
| Q1 2019Quarterly · 2019-03-31 | Product | Collaboration And License | 14,238,000 | USD | 0001564590-19-016079 |
| Q1 2019Quarterly · 2019-03-31 | Product | Product | 3,934,000 | USD | 0001564590-19-016079 |
| FY 2018Yearly · 2018-12-31 | Geography | All Other | 863,000 | USD | 0001564590-21-005610 |
| FY 2018Yearly · 2018-12-31 | Geography | Europe | 5,293,000 | USD | 0001564590-21-005610 |
| FY 2018Yearly · 2018-12-31 | Geography | North America | 45,339,000 | USD | 0001564590-21-005610 |
| Q3 2018Quarterly · 2018-09-30 | Product | Collaboration And License | 9,015,000 | USD | 0001564590-19-040541 |
| Q3 2018Quarterly · 2018-09-30 | Product | Product | 2,748,000 | USD | 0001564590-19-040541 |
| Q2 2018Quarterly · 2018-06-30 | Product | Collaboration And License | 10,519,000 | USD | 0001564590-19-028087 |
| Q2 2018Quarterly · 2018-06-30 | Product | Product | 2,275,000 | USD | 0001564590-19-028087 |
| FY 2017Yearly · 2017-12-31 | Product | Collaboration And License | 2,136,000 | USD | 0001564590-20-004667 |
| FY 2017Yearly · 2017-12-31 | Product | Collaboration And Royalty | 9,000 | USD | 0001564590-20-004667 |
| FY 2017Yearly · 2017-12-31 | Product | Product | 476,000 | USD | 0001564590-20-004667 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.